These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 1576352)

  • 21. A practical approach to planar and SPECT imaging of 111In-CYT-103.
    Collier BD; Trembath LA; Liu Y; Turoglu HT; Patel N; Thakur S
    Targeted Diagn Ther; 1992; 6():191-210. PubMed ID: 1576346
    [No Abstract]   [Full Text] [Related]  

  • 22. [Immunoscintigraphy of prostatic cancer].
    Aliaev IuG; Vinarov AZ; Rapoport LM; Bezrukov EA; Butnaru DV
    Urologiia; 2006; (4):67-9. PubMed ID: 17058687
    [No Abstract]   [Full Text] [Related]  

  • 23. Radioimmunoscintigraphy of colorectal carcinomas with three different radiopharmaceuticals.
    Obradovic V; Artiko V; Petrovic M; Lausevic Z; Stojkovic M; Sobic-Saranovic D; Petrovic N; Vlajkovic M; Krivokapic Z
    Neoplasma; 2006; 53(5):444-9. PubMed ID: 17013541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of In-111 labeled CYT-103 immunoscintigraphy in the evaluation of patients with recurrent colorectal carcinoma.
    Markowitz A; Saleemi K; Freeman LM
    Clin Nucl Med; 1993 Aug; 18(8):685-700. PubMed ID: 8403703
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative analysis of In-111 satumomab pendetide immunoscintigraphy. An aid to visual interpretation of images in patients with suspected carcinomatosis.
    Neal CE; Johnson DL; Cornwell VL; Markwell S
    Clin Nucl Med; 1996 Aug; 21(8):638-42. PubMed ID: 8853918
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Challenges in immunoscintigraphy of ovarian cancer.
    Kim EE; Kasi LP
    Gynecol Oncol; 1993 Mar; 48(3):283-4. PubMed ID: 8462895
    [No Abstract]   [Full Text] [Related]  

  • 27. Lipomas as a potential cause for uptake of In-111 MAb72.3 (Oncoscint CR).
    Sakow NK; Japanwalla M; Tuckson WB; Shields RE
    Clin Nucl Med; 1996 Apr; 21(4):332-3. PubMed ID: 8925626
    [No Abstract]   [Full Text] [Related]  

  • 28. [Usefulness of scintigraphy images with 111In-CYT-103 in the diagnosis of colonic and rectal recurrence].
    García-Fernández R; Luna-Pérez P; Hernández-Hernández DM; Iwasaki-Otake L; Pichardo-Romero P; Rodríguez-Ramirez S
    Gac Med Mex; 2002; 138(2):139-44. PubMed ID: 12001423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In-111 CYT-103 immunoscintigraphy of isolated splenic metastasis from ovarian carcinoma.
    Nguyen BD; Regan F
    Clin Nucl Med; 1997 Apr; 22(4):256-7. PubMed ID: 9099487
    [No Abstract]   [Full Text] [Related]  

  • 30. Splenic metastasis from colon carcinoma imaged using In-111 OncoScint.
    Pieslor PC; White CA; Varney RR
    Clin Nucl Med; 1995 Jun; 20(6):553-4. PubMed ID: 7648747
    [No Abstract]   [Full Text] [Related]  

  • 31. Immunoscintigraphy of primary colorectal cancers with indium-111 monoclonal antibody B72.3.
    Joypaul BV; Kennedy N; Hanson J; Holley M; Browning M; Newman EL; Cuschieri A
    J R Coll Surg Edinb; 1994 Feb; 39(1):39-43. PubMed ID: 7515429
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of iodine-123-vasoactive intestinal peptide receptor scintigraphy and indium-111-CYT-103 immunoscintigraphy.
    Raderer M; Becherer A; Kurtaran A; Angelberger P; Li S; Leimer M; Weinlaender G; Kornek G; Kletter K; Scheithauer W; Virgolini I
    J Nucl Med; 1996 Sep; 37(9):1480-7. PubMed ID: 8790198
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Indium-111 monoclonal antibody B72.3 scintigraphy in colorectal cancer. Correlation with computed tomography, surgery, histopathology, immunohistology, and human immune response.
    Winzelberg GG; Grossman SJ; Rizk S; Joyce JM; Hill JB; Atkinson DP; Sudina K; Anderson K; McElwain D; Jones AM
    Cancer; 1992 Apr; 69(7):1656-63. PubMed ID: 1551051
    [TBL] [Abstract][Full Text] [Related]  

  • 34. False-positive imaging of In-111 labeled monoclonal antibody conjugate CYT-103 in a patient with metastatic colorectal carcinoma.
    Bhatia M; Baron PL; Alderman DF; Gordon L
    Clin Nucl Med; 1995 Nov; 20(11):979-80. PubMed ID: 8565379
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radiation absorbed dose estimates for indium-111-labeled B72.3, an IgG antibody to ovarian and colorectal cancer: MIRD dose estimate report No. 18.
    Mardirossian G; Brill AB; Harwood SJ; Olsen J; Dwyer KA; Siegel JA
    J Nucl Med; 1998 Apr; 39(4):671-6. PubMed ID: 9544680
    [No Abstract]   [Full Text] [Related]  

  • 36. Intense uptake of In-111 satumomab pendetide in an inflammatory mass.
    Silberstein EB; Saeks E
    Clin Nucl Med; 1996 Jan; 21(1):53-5. PubMed ID: 8741891
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic use of radiolabeled antibodies for cancer.
    Harrison KA; Tempero MA
    Oncology (Williston Park); 1995 Jul; 9(7):625-31 DISC 634, 636, 641. PubMed ID: 8924373
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In-111 CYT-103 immunoscintigraphy in the imaging of ovarian carcinoma.
    Neal CE; Baker MR; Hilgers RD; Fanning J; Burke RC; Snodgrass J; Cull RD
    Clin Nucl Med; 1993 Jun; 18(6):472-6. PubMed ID: 8319398
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Uptake of In-111 GYK-DTPA B72.3 monoclonal antibody in metastatic squamous cell carcinoma.
    Blend MJ; De La Coates-Johnson R
    Clin Nucl Med; 1994 Oct; 19(10):912-3. PubMed ID: 7805331
    [No Abstract]   [Full Text] [Related]  

  • 40. Immunoscintigraphy of colorectal cancer using a monoclonal antibody 77-1.
    Yiu CY; Baker LA; Davidson BR; McCready VR; Boulos PB
    Eur J Surg Oncol; 1991 Oct; 17(5):495-501. PubMed ID: 1936297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.